Publication
Paper co-authored by YUIRYOU's Tomohiro Mitoma published in Gynecologic Oncology
A paper co-authored by Tomohiro Mitoma of YUIRYOU has been published in Gynecologic Oncology — a scoping review on the effectiveness of exercise therapy for chemotherapy-induced peripheral neuropathy (CIPN) in ovarian cancer patients.
Tomohiro Mitoma, CEO of YUIRYOU Inc. (OB-GYN), has co-authored a paper published in Gynecologic Oncology. The study is a scoping review examining the effectiveness of exercise therapy on chemotherapy-induced peripheral neuropathy (CIPN) in patients with ovarian cancer.
Paper information
- Title: Effectiveness of exercise therapy on chemotherapy-induced peripheral neuropathy in patients with ovarian cancer: A scoping review
- Journal: Gynecologic Oncology (2025)
- Authors: Masanori Konuma et al. (Tomohiro Mitoma, co-author)
- DOI: 10.1016/j.ygyno.2024.12.007
Our involvement
From research design through statistical analysis to English-language publication, these capabilities are directly aligned with the clinical research and publication support YUIRYOU provides to healthcare companies.
The author's publication list is available on researchmap.